The mission of the National Institutes of Health is to improve the health status of all Americans through biomedical research and scientific training and education. To reach this goal we need to succeed in developing a diverse group of scientists ready to make breakthroughs that result in the development of novel therapies to treat current killer diseases and the reduction and ultimate elimination of current health disparities. The mission of the Initiative for Maximizing Student Diversity Program (IMSD) at Loma Linda University is to increase diversity in the cadre of students that graduate with PhD or MD-PhD degrees at this institution. To accomplish this goal, this competitive renewal application proposes a comprehensive plan that should lead to an increase in the number of underrepresented minority students (URMS) that graduate with a PhD degree from Loma Linda University. The program especially focuses in identifying and removing hurdles that can inhibit success of URMS in graduate school. The goal of the application is to double the number of URMS that graduate with a PhD degree in the biomedical sciences at LLU. The application will accomplish this goal by meeting six specific measurable objectives: (1) To recruit and support 5 new promising URMS per year that participate in the LLU- NIH IMSD program. (2) To achieve a 100% graduation rate of PhD students participating in the program. (3) To provide a supportive academic and financial environment to all LLU IMSD students. (4) To enhance the academic and research proficiency of all LLU IMSD students through participation in co-curricular activities such as modules on scientific writing and communication, research proposal development, and teaching skills. (5) To have all LLU IMSD students attend at least one major national and two regional/local scientific meetings per year, and publish a minimum of two first author manuscripts during the PhD. (6) To increase the number of graduate URMS who are proficient in the field of health disparities through participation in a 1-unit topic course on health disparities. The LLU-NIH IMSD program has been successful in reaching its goals and objectives because of the development of a robust internal pipeline of diversity programs, and a continued partnership with diversity programs from collaborating institutions around the country that share with us the vision of training a diverse workforce of biomedical scientists. Public health relevance: Finding the cure of current killer diseases in the USA requires developing a diverse cadre of biomedical scientists that are well trained and equipped to pursue cutting-edge basic and translational science research. The present application contains a comprehensive educational developmental plan that addresses well known hurdles that interfere with the aspirations of universities across the country in increasing the number of PhD graduates from students underrepresented in biomedical sciences.
Finding the cure of current killer diseases in USA requires developing a diverse cadre of biomedical scientists that are well trained and equipped to pursue cutting edge basic and translational science research. The present application contains a comprehensive educational developmental plan that addresses well known hurdles that interfere with the aspirations of universities across the country in increasing the number of PhD graduates from students underrepresented in biomedical sciences.
|Gardner, Susan A; Salto, Lorena M; Riggs, Matt L et al. (2018) Supporting the Writing Productivity of Biomedical Graduate Students: An Integrated, Structured Writing Intervention. CBE Life Sci Educ 17:ar45|
|Cajigas-Du Ross, Christina K; Martinez, Shannalee R; Woods-Burnham, Leanne et al. (2018) RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance. Oncotarget 9:30363-30384|
|Rowland, Leah K; Campbell, Petreena S; Mavingire, Nicole et al. (2018) Putative tumor suppressor cytoglobin promotes aryl hydrocarbon receptor ligand-mediated triple negative breast cancer cell death. J Cell Biochem :|
|Woods-Burnham, Leanne; Cajigas-Du Ross, Christina K; Love, Arthur et al. (2018) Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells. Sci Rep 8:15063|
|Woods-Burnham, Leanne; Stiel, Laura; Wilson, Colwick et al. (2018) Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making. Am J Mens Health 12:751-759|
|Campbell, Petreena S; Mavingire, Nicole; Khan, Salma et al. (2018) AhR ligand aminoflavone suppresses ?6-integrin-Src-Akt signaling to attenuate tamoxifen resistance in breast cancer cells. J Cell Physiol 234:108-121|
|Lindsey, Richard C; Rundle, Charles H; Mohan, Subburaman (2018) Role of IGF1 and EFN-EPH signaling in skeletal metabolism. J Mol Endocrinol 61:T87-T102|
|Cordero, Kathia; Coronel, Gemma G; Serrano-Illán, Miguel et al. (2018) Effects of Dietary Vitamin E Supplementation in Bladder Function and Spasticity during Spinal Cord Injury. Brain Sci 8:|
|Greer-Phillips, Suzanne E; Sukomon, Nattakan; Chua, Teck Khiang et al. (2018) THE AER2 RECEPTOR FROM VIBRIO CHOLERAE IS A DUAL PAS-HEME OXYGEN SENSOR. Mol Microbiol :|
|Garcia, Darysbel; Orillard, Emilie; Johnson, Mark S et al. (2017) Gas Sensing and Signaling in the PAS-Heme Domain of the Pseudomonas aeruginosa Aer2 Receptor. J Bacteriol 199:|
Showing the most recent 10 out of 122 publications